Evidence map›Paper›PMID 34501934›Full record

ArticleInternational journal of environmental research and public health2021

Interferon-γ-Inducible Chemokines as Prognostic Markers for Lung Cancer.

Keu-Sung Lee, Wou-Young Chung, Ji-Eun Park, Yun-Jung Jung, Joo-Hun Park, Seung-Soo Sheen, Kwang-Joo Park

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  7. Article
  8. Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Keu-Sung LeeDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.
Wou-Young ChungDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0002-5435-2787
Ji-Eun ParkDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0002-3035-6353
Yun-Jung JungDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0002-8887-0881
Joo-Hun ParkDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.
Seung-Soo SheenDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.
Kwang-Joo ParkDepartment of Pulmonology and Critical Care Medicine, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0001-5870-1836
Ajou University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon (IFN)-γ-inducible chemokines in the CXCR3/ligand axis are involved in cell-mediated immunity and play a significant role in the progression of cancer. We enrolled patients with lung cancer (

Indexed as

Carcinoma, Non-Small-Cell LungChemokines, CLung NeoplasmsChemokine CXCL10HumansInterferon-gammaInterferonsPrognosisChemokine CXCL10Chemokines, CInterferon-gammaInterferonsbiomarkercell-mediated immunityCXCR3 ligandinterferon-γlung cancerprognosis

Identifiers

PMID34501934
PMCPMC8431216
OpenAlexW3198750111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.